COVID-19 and Mesothelioma Updates
COVID-19 and mesothelioma is a dangerous combination. As new variants, like Omicron, emerge, cancer patients and their families must be aware of the changing risks.
COVID-19 and mesothelioma is a dangerous combination. As new variants, like Omicron, emerge, cancer patients and their families must be aware of the changing risks.
Asbestos contamination in the town of Wittenoom in Western Australia has claimed at least 1,200 residents’ lives, but the fear of mesothelioma and lung cancer has not been enough to keep tourists away, or even to chase away residents. Now the government is taking drastic steps. A bill authorizing clearing the former town and compensating
Researchers in Italy and the Netherlands identified a remarkable result when analyzing survival outcomes of mesothelioma patients in a recent study of PD-1 inhibitors. They found that the positive impact of the promising treatment was elevated among patients taking statin drugs for the treatment of high cholesterol.
In preparation for her presentation at the PER New York Lung Cancer Symposium, Marjorie G. Zauderer, M.D., co-director of the MSK Mesothelioma Program at Memorial Sloan Kettering Cancer Center in New York City, provided an interview to the journal OncLive. Her responses gave a glimpse into the future of the disease’s treatment options, as well
A recently completed phase I trial conducted by researchers at Memorial Sloan Kettering Cancer center has shown a safe and positive response in mesothelioma patients, according to a report published in the journal Cancer Discovery. After scientists administered chimeric antigen receptor T-cell (CAR-T) therapy followed by Keytruda, 83 percent of patients were alive one year later.
If you see “Cause of Death: Mesothelioma” on a death certificate, you may be wondering what it is or how this happened. Mesothelioma is a rare cancer most often associated with asbestos exposure. In most cases, a company or employer can be held accountable for exposure and resulting illness. What Is Mesothelioma? Mesothelioma is a
It’s been a long time coming, but the Environmental Protection Agency (EPA) and advocacy groups including the Asbestos Disease Awareness Organization (ADAO) have reached an important agreement regarding the mineral that causes mesothelioma. Activists have been pushing for a comprehensive second risk evaluation for asbestos, and are hailing the new consensus as a victory.
In a study of the effectiveness of focused radiation following chemotherapy, Italian researchers have found that mesothelioma patients receiving the protocol enjoyed longer periods of progression-free health and a slower return of their tumors.
Despite the best efforts of scientists around the globe, malignant pleural mesothelioma continues to carry an extremely poor prognosis, with a five-year survival rate of just 10%. Still, patients are benefitting from research. The Checkmate-743 trial recently yielded a report of increased durable overall survival in mesothelioma from the immunotherapy combination of nivolumab and ipilimumab.
In assessing potential risk factors and outcomes for patients diagnosed with malignant mesothelioma, there have long been questions about whether a patient’s socioeconomic status plays a role in their access to quality care. A study conducted by researchers from the University of Miami’s Sylvester Comprehensive Cancer Center examined the issue and found significant variability.